Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
DR-01 antibody treatment for nonsegmental vitiligo
Official title: A Pilot, Safety and Clinical Activity, Phase 1b Study of DR-01 in Adults With Alopecia Areata or Vitiligo
Description:
DR-01 is an experimental intravenous antibody intended to reduce disease-driving immune cells. Researchers from Dren Bio hope it will lessen the attack on melanocytes and allow repigmentation. Possible risks include infusion reactions, headache, changes in blood counts, and infections; its full safety profile is not yet known.
People age 18 and older may qualify. The study is underway but is no longer accepting new participants. Dren Bio enrolled about 81 participants.
Start date: October 30, 2024
Completion date: May 01, 2027
Contact: Michael Rothenberg, MD, PhD
Tel.: Not reported
Email: Not reported
Link: Not reported
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
- What joining a clinical trial actually looks like?
Pediatric vitiligo trials · Taking part Cream twice a day, scheduled visits and the practical questions every mother asks before committing the family calendar. The studies disc...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.